J M Harrelson
Overview
Explore the profile of J M Harrelson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
1147
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Berend K, Pietrobon R, Moore J, Dibernardo L, Harrelson J, Scully S
J Surg Oncol
. 2001 Dec;
78(3):162-70.
PMID: 11745799
Background And Objectives: Osteosarcoma is a primary malignancy of bone. Current therapy includes neoadjuvant chemotherapy, surgery, and postoperative (adjuvant) chemotherapy. Prolonged treatment with chemotherapeutic agents may place patients at increased...
2.
Ghert M, Jung S, Qi W, Harrelson J, Erickson H, Block J, et al.
Oncology
. 2001 Nov;
61(4):306-14.
PMID: 11721178
Objectives: Tenascin-C (TNC) is an oligomeric glycoprotein of the extracellular matrix that is prominently expressed in malignant tumors. The purpose of this study was: (1) to determine the in vitro...
3.
Rizzo M, Ghert M, Harrelson J, Scully S
Clin Orthop Relat Res
. 2001 Oct;
(391):224-33.
PMID: 11603673
Chondrosarcoma is the second most common malignant bone tumor and is relatively unresponsive to chemotherapy and radiation regimens. In addition, the clinical course of chondrosarcoma is difficult to predict. The...
4.
Maguire P, Samulski T, Prosnitz L, Jones E, Rosner G, Powers B, et al.
Int J Hyperthermia
. 2001 Jul;
17(4):283-90.
PMID: 11471980
We prospectively evaluated whether delivering a thermal dose of > 10 cumulative equivalent minutes at 43 degrees C to >90% of the tumour sites monitored (CEM43 degrees T90) would produce...
5.
Ghert M, Harrelson J, Scully S
J Hand Surg Am
. 2001 Feb;
26(1):156-60.
PMID: 11172383
Metastatic renal cell carcinoma responds poorly to chemotherapy or radiation therapy and is associated with a dismal survival rate. In cases of a solitary acrometastasis, the literature supports complete resection...
6.
Layfield L, Liu K, Shepard R, Harrelson J
Arch Pathol Lab Med
. 2000 Nov;
124(11):1636-41.
PMID: 11079016
Context: Pigmented villonodular synovitis (PVNS) is a well-recognized entity that has the potential for extensive local destruction, even though it rarely metastasizes. Rare reports of malignant forms are recorded in...
7.
Pringle T, Harrelson J, West R, Williams S, Johnson D
J Anim Sci
. 2000 Jan;
77(12):3230-7.
PMID: 10641869
Steers of known percentage Brahman (B) and Angus (A) breeding (100% A, n = 6; F1 B x A, n = 6; and 100% B, n = 6) were used...
8.
Prosnitz L, Maguire P, Anderson J, Scully S, Harrelson J, Jones E, et al.
Int J Radiat Oncol Biol Phys
. 1999 Nov;
45(4):941-9.
PMID: 10571201
Purpose: To explore the use of a novel program of preoperative radiation and hyperthermia in the management of high-grade soft tissue sarcomas (STS). Methods And Materials: Eligible patients were adults...
9.
Scully S, Berend K, Qi W, Harrelson J
Braz J Med Biol Res
. 1999 Aug;
32(7):885-9.
PMID: 10454748
The treatment of some mesenchymal malignancies has made significant gains over the past few decades with the development of effective systemic therapies. In contrast, the treatment of chondrosarcoma has been...
10.
Scully S, Temple H, Harrelson J
Clin Orthop Relat Res
. 1999 Jul;
(364):220-6.
PMID: 10416412
Synovial sarcoma of the foot and ankle frequently is misdiagnosed, which leads to delays in treatment. The clinical records of 14 patients with synovial sarcoma of the foot and ankle...